Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)
- PMID: 20091563
- DOI: 10.1002/14651858.CD004379.pub3
Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)
Abstract
Background: The success of in-vitro fertilisation (IVF) depends on adequate follicle recruitment by using controlled ovarian stimulation with gonadotrophins. Failure to recruit adequate follicles is called 'poor response'. Various treatment protocols have been proposed that are targeted at this cohort of women, aiming to increase their ovarian response.
Objectives: To compare the effectiveness of different treatment interventions in women who have poor response to controlled ovarian hyperstimulation (are poor responders) in the context of IVF.
Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (MDSG) (5/1/2009), the Cochrane Central Register of Controlled trials (CENTRAL) (4th Quarter 2008), MEDLINE (1950 to November week 3 2008), EMBASE (1980 to 2008 week 52) and The National Research Register (NRR). The citation lists of relevant publications, review articles, abstracts of scientific meetings and included studies were also searched. The authors were contacted to clarify data that were unclear from the trial reports.
Selection criteria: Only randomised controlled trials (RCTs) comparing one type of intervention versus another for controlled ovarian stimulation of poor responders to a previous IVF treatment, using a standard long protocol were included.
Data collection and analysis: Two reviewers independently scanned the abstracts, identified relevant papers, assessed trial quality and extracted relevant data for inclusion. Validity was assessed in terms of method of randomisation, completeness of treatment cycle and co-intervention. Where possible, data were pooled for analysis.
Main results: The new search identified fifteen trials. Three trials were eligible for inclusion. Ten trials involving eight different comparison groups have been included. Only one trial reported live birth rates.The number of oocytes retrieved were significantly less in the conventional GnRHa long protocol compared to stop protocol and GnRH antagonist protocol.Total dose of gonadotrophins used was significantly higher in the GnRHa long protocol group compared to the Stop protocol and GnRH antagonist groups.Cancellation rates were significantly higher in the GnRHa flare up group compared to the GnRHa long protocol group.None of the studies reported a difference in the miscarriage and ectopic pregnancy rates.
Authors' conclusions: There is insufficient evidence to support the routine use of any particular intervention either for pituitary down regulation, ovarian stimulation or adjuvant therapy in the management of poor responders to controlled ovarian stimulation in IVF. More robust data from good quality RCTs with relevant outcomes are needed.
Update of
-
Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF).Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004379. doi: 10.1002/14651858.CD004379.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004379. doi: 10.1002/14651858.CD004379.pub3. PMID: 17253503 Updated.
Similar articles
-
Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF).Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004379. doi: 10.1002/14651858.CD004379.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004379. doi: 10.1002/14651858.CD004379.pub3. PMID: 17253503 Updated.
-
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3. Cochrane Database Syst Rev. 2017. PMID: 29096046 Free PMC article.
-
Growth hormone for in vitro fertilisation (IVF).Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD000099. doi: 10.1002/14651858.CD000099.pub4. Cochrane Database Syst Rev. 2021. PMID: 34808697 Free PMC article.
-
Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD002808. doi: 10.1002/14651858.CD002808.pub3. Cochrane Database Syst Rev. 2013. PMID: 23440788 Free PMC article.
-
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD001750. doi: 10.1002/14651858.CD001750.pub4. Cochrane Database Syst Rev. 2016. PMID: 27126581 Free PMC article.
Cited by
-
GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study.PLoS One. 2018 Nov 7;13(11):e0207081. doi: 10.1371/journal.pone.0207081. eCollection 2018. PLoS One. 2018. PMID: 30403766 Free PMC article.
-
VEGF Concentration in a Preovulatory Leading Follicle Relates to Ovarian Reserve and Oocyte Maturation during Ovarian Stimulation with GnRH Antagonist Protocol in In Vitro Fertilization Cycle.J Clin Med. 2021 Oct 28;10(21):5032. doi: 10.3390/jcm10215032. J Clin Med. 2021. PMID: 34768551 Free PMC article.
-
Evaluation of the Second Follicular Wave Phenomenon in Natural Cycle Assisted Reproduction: A Key Option for Poor Responders through Luteal Phase Oocyte Retrieval.Medicina (Kaunas). 2019 Mar 14;55(3):68. doi: 10.3390/medicina55030068. Medicina (Kaunas). 2019. PMID: 30875815 Free PMC article.
-
Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.Reprod Biol Endocrinol. 2018 Sep 17;16(1):90. doi: 10.1186/s12958-018-0409-z. Reprod Biol Endocrinol. 2018. PMID: 30223902 Free PMC article.
-
Cumulative live birth rates in low-prognosis women.Hum Reprod. 2019 Jun 4;34(6):1030-1041. doi: 10.1093/humrep/dez051. Hum Reprod. 2019. PMID: 31125412 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical